drugset / Trial / NCT01115543

Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism

NCT01115543

Phase 4 Completed 32 enrolled Mahidol University
RandomizedCrossoverSingle-blindTreatment

Summary

This study was performed to determine whether calcitriol provides a therapeutic advantage to alfacalcidol for treatment of secondary hyperparathyroidism in ESRD patients.

Timeline

Start
2008-08
Primary completion
2009-08
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Alfacalcidol Other / unclassified
Subject Calcitriol Small molecule